Patient-centered physician with postgraduate degree in life sciences (Ph.D. 2000 - Cell and Molecular Biology) from the University of Edinburgh, U.K., post-doctoral certification in Oncology Research from the Mayo Clinic Rochester, MN, and long-term experience in medical safety (director level) in Germany, Austria, Switzerland, United Kingdom, Ireland, Italy, and Czech Republic. Scientific partner to Brighton Collaboration. Safety physician, clinical advisor and author for Cochrane Clinical Answers – Hematology & Oncology and Psychiatry. Director and owner of SG Consulting in Darmstadt, Germany. The company is setting the praxis standards in providing independent medical safety case reviews, aggregate safety reports and signal detection services for a wide range of therapeutic specialties and sub-specialties. The range of services offer reliable support to safety governance and risk management activities including characterization of identified and potential medication/therapy risks, proposals for mitigation/minimization measures, safety go-no go criteria for the clinical programs, and definition of the risk component of expert benefit/risk assessments; acts as safety-related point-of-contact to national Health Authorities in various European countries, Switzerland, and the United Kingdom, and provides responses to regulatory safety queries. SG Consulting also offers specialized medical translations from various European languages into English and/or German.
Name: Univ of Edinburgh (Great Brita
Degree: Ph.D.
Specialty: Molecular Biology
Year: 2000
Name:
Cochrane Clinical Answers (CCA) Hematology/Oncology
Role: Clinical Advisor and Author / Cochrane Member
Name:
AMSP e.V. (Arzneimittelsicherheit in der Psychiatrie e.V.)
Role: Member
Name:
PBV (Privatärztlicher bundesverband e.V.) - Germany
Role: Member
Name:
BSG (British Society for Gastroenterology)
Role: Member
Name:
DGHO (German Society for Hematology and Medical Oncology e.V.)
Role: Member
Name:
Clinical Pharmacometrics Special Interest Group (SIG)
Role: Member of the Educational Committee
Name:
WHO Collaborating Centre (UMC)
Role: Partner
Name:
Brighton Collaboration
Role: Scientific Partner
Immunotherapy and cell-based therapies for solid cancer, secondary AML, rare diseases